CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2023
Voltar para busca
Dado oficial do USPTO
NEXAPI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEXAPI
ST13
US500000090302936Classe
1, 5, 40, 42
Pedido
90302936
Registro
6566227
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/03/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
06/11/2020
Data de registro
23/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/11/2021
Última transação
03/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Paris, FR
Examinador
MARTIN, CHRISTINE C
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Sanofi
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science
Classe 5
Pharmaceutical preparations for the treatment of cardiovascular diseasescentral and peripheral nervous system diseasesrespiratory diseasescancerallergiesgynecological diseasesrheumatic diseasesurological diseasesgastroenterological diseasesinfectious diseaseseye diseasedermatological diseasesautoimmune diseasesblood diseasesgenital diseasesendocrine diseasesintestinal diseasesinternal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food supplements for human beings and animals; disinfectants; biochemicalsmonoclonal antibodies for pharmaceutical use
Classe 40
Treatment of chemicalscustom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; Technical and scientific servicesproviding technical information in the field of pharmaceutical manufacturing
Classe 42
Research and development services in the field of health and biotechnologiesresearch in the area of the development of new active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological servicesconsulting and assistance in the research and development of pharmaceuticals; scientific and technical servicesscientific analysis of industrial installations; scientific research and development services in the field of pharmaceuticals; scientific research and development services for chemicals for the products of third partiesthe scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and scientific and technical development in the field of pharmaceuticalchemicalagrochemical and industrial processes; scientific servicesscientific research and industrial analysis in the field of pharmaceuticalschemicalsagrochemical and industrial processes; scientific servicesscientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological servicesapplied scientific research and development servicesconception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceuticalchemical or agrochemical products; engineering servicesformulationprocess evaluation and project management in the scientific and industrial fieldsmainly in the chemical and pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; scientific and technological servicesconsulting and assistance in the research and development of chemicals and pharmaceuticalsincluding experimental and production processes and installations
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
23/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2021
PUBO
PUBLISHED FOR OPPOSITION
07/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2021
ALIE
ASSIGNED TO LIE
29/07/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/07/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/02/2021
GNSL
LETTER OF SUSPENSION E-MAILED
16/02/2021
CNSL
SUSPENSION LETTER WRITTEN
16/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/01/2021
GNRT
NON-FINAL ACTION E-MAILED
22/01/2021
CNRT
NON-FINAL ACTION WRITTEN
22/01/2021
DOCK
ASSIGNED TO EXAMINER
20/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2021
NWAP
NEW APPLICATION ENTERED
10/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEXAPI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.